Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

NCT00698126 · clinicaltrials.gov ↗

COMPLETED

Status

4099

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: soluble human insulin
DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S